EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients. Blumenthal, M. J, Schutz, C., Meintjes, G. A, Mohamed, Z., Mendelson, M., Ambler, J. M, Whitby, D., Mackelprang, R. D, Carse, S., Katz, A. A, & Schäfer, G. Cancer Epidemiology, 56:133–139, Elsevier, oct, 2018.
EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients [link]Paper  doi  abstract   bibtex   
BACKGROUND To determine if variations exist in the KSHV host receptor EPHA2′s coding region that affect KSHV infectivity and/or KS prevalence among South African HIV-infected patients. METHODS A retrospective candidate gene association study was performed on 150 patients which were randomly selected from a total of 756 HIV-infected patients and grouped according to their KS status and KSHV serodiagnosis; namely group 1: KS+/KSHV+; group 2: KS−/KSHV+; group 3: KS−/KSHV−. Peripheral blood DNA was used to extract DNA and PCR amplify and sequence the entire EPHA2 coding region, which was compared to the NCBI reference through multiple alignment. RESULTS 100% (95% CI 92.9–100%) of the KS positive patients, and 31.6% (95% CI 28.3–35.1%) of the KS negative patients were found to be KSHV seropositive. Aggregate variation across the entire EPHA2 coding region identified an association with KS (OR = 6.6 (95% CI 2.8, 15.9), p = 2.2 × 10−5). This was primarily driven by variation in the functionally important protein tyrosine kinase domain (Pkinase-Tyr; OR = 4.9 (95% CI 1.9, 12.4), p = 0.001) and the sterile-$α$-motif (SAM; OR = 13.8 (95% CI 1.7, 111.6), p = 0.014). Mutation analysis revealed two novel, non-synonymous heterozygous variants (c.2254 T \textgreater C: OR undefined, adj. p = 0.02; and c.2990 G \textgreater T: OR undefined, adj. p = 0.04) in Pkinase-Tyr and SAM, respectively, to be statistically associated with KS; and a novel heterozygous transition (c.2727C \textgreater T: OR = 6.4 (95% CI 1.4, 28.4), adj. p = 0.03) in Pkinase-Tyr to be statistically associated with KSHV. CONCLUSIONS Variations in the KSHV entry receptor gene EPHA2 affected susceptibility to KSHV infection and KS development in a South African HIV-infected patient cohort.
@article{Blumenthal2018,
abstract = {BACKGROUND To determine if variations exist in the KSHV host receptor EPHA2′s coding region that affect KSHV infectivity and/or KS prevalence among South African HIV-infected patients. METHODS A retrospective candidate gene association study was performed on 150 patients which were randomly selected from a total of 756 HIV-infected patients and grouped according to their KS status and KSHV serodiagnosis; namely group 1: KS+/KSHV+; group 2: KS−/KSHV+; group 3: KS−/KSHV−. Peripheral blood DNA was used to extract DNA and PCR amplify and sequence the entire EPHA2 coding region, which was compared to the NCBI reference through multiple alignment. RESULTS 100{\%} (95{\%} CI 92.9–100{\%}) of the KS positive patients, and 31.6{\%} (95{\%} CI 28.3–35.1{\%}) of the KS negative patients were found to be KSHV seropositive. Aggregate variation across the entire EPHA2 coding region identified an association with KS (OR = 6.6 (95{\%} CI 2.8, 15.9), p = 2.2 × 10−5). This was primarily driven by variation in the functionally important protein tyrosine kinase domain (Pkinase-Tyr; OR = 4.9 (95{\%} CI 1.9, 12.4), p = 0.001) and the sterile-$\alpha$-motif (SAM; OR = 13.8 (95{\%} CI 1.7, 111.6), p = 0.014). Mutation analysis revealed two novel, non-synonymous heterozygous variants (c.2254 T {\textgreater} C: OR undefined, adj. p = 0.02; and c.2990 G {\textgreater} T: OR undefined, adj. p = 0.04) in Pkinase-Tyr and SAM, respectively, to be statistically associated with KS; and a novel heterozygous transition (c.2727C {\textgreater} T: OR = 6.4 (95{\%} CI 1.4, 28.4), adj. p = 0.03) in Pkinase-Tyr to be statistically associated with KSHV. CONCLUSIONS Variations in the KSHV entry receptor gene EPHA2 affected susceptibility to KSHV infection and KS development in a South African HIV-infected patient cohort.},
author = {Blumenthal, Melissa J and Schutz, Charlotte and Meintjes, Graeme A and Mohamed, Zainab and Mendelson, Marc and Ambler, Jon M and Whitby, Denise and Mackelprang, Romel D and Carse, Sinead and Katz, Arieh A and Sch{\"{a}}fer, Georgia},
doi = {10.1016/J.CANEP.2018.08.005},
journal = {Cancer Epidemiology},
keywords = {OA,fund{\_}not{\_}ack,original},
mendeley-tags = {OA,fund{\_}not{\_}ack,original},
month = {oct},
pages = {133--139},
pmid = {30176543},
publisher = {Elsevier},
title = {{EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients}},
url = {https://www.sciencedirect.com/science/article/pii/S1877782118302480?via{\%}3Dihub},
volume = {56},
year = {2018}
}

Downloads: 0